Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V McAuliffe

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Nursing Review|April 5, 2002
Hasten slowly: a needs analysis for nurse and village health worker education in East TimorA V McAuliffe, J Grootjans, J E M Fisher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococciS Handwerger, D C Perlman, D Altarac, et al.
Journal of Clinical Microbiology|September 1, 1978
Third component, HBeAg/3, of hepatitis B e antigen system, identified by three different double-diffusion techniquesB Murphy, E Tabor, V McAuliffe, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1996
Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuraA V McAuliffe, E J Fisher, S V McLennan, et al.
Nephron|November 10, 1998
Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretionA V McAuliffe, B A Brooks, E J Fisher, et al.
Diabetes Research and Clinical Practice|August 1, 1997
High glucose inhibits effect of ascorbic acid on [35S] sulphate incorporation in mesangial cell and matrix proteoglycanA V McAuliffe, E J Fisher, S V McLennan, et al.
Infection and Immunity|January 1, 1983
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodiesH Greenberg, V McAuliffe, J Valdesuso, et al.
Annals of Internal Medicine|March 13, 1999
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258R M Gulick, V McAuliffe, J Holden-Wiltse, et al.
Journal of Virology|August 1, 1983
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirusH B Greenberg, J Valdesuso, K van Wyke, et al.
The Journal of Infectious Diseases|August 19, 2000
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333M F Para, D V Glidden, R W Coombs, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Nursing Review|April 5, 2002
Hasten slowly: a needs analysis for nurse and village health worker education in East TimorA V McAuliffe, J Grootjans, J E M Fisher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococciS Handwerger, D C Perlman, D Altarac, et al.
Journal of Clinical Microbiology|September 1, 1978
Third component, HBeAg/3, of hepatitis B e antigen system, identified by three different double-diffusion techniquesB Murphy, E Tabor, V McAuliffe, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1996
Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuraA V McAuliffe, E J Fisher, S V McLennan, et al.
Nephron|November 10, 1998
Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretionA V McAuliffe, B A Brooks, E J Fisher, et al.
Diabetes Research and Clinical Practice|August 1, 1997
High glucose inhibits effect of ascorbic acid on [35S] sulphate incorporation in mesangial cell and matrix proteoglycanA V McAuliffe, E J Fisher, S V McLennan, et al.
Infection and Immunity|January 1, 1983
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodiesH Greenberg, V McAuliffe, J Valdesuso, et al.
Annals of Internal Medicine|March 13, 1999
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258R M Gulick, V McAuliffe, J Holden-Wiltse, et al.
Journal of Virology|August 1, 1983
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirusH B Greenberg, J Valdesuso, K van Wyke, et al.
The Journal of Infectious Diseases|August 19, 2000
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333M F Para, D V Glidden, R W Coombs, et al.
Pageof 2